Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

Ohtsuji, Michio; Yagi, Kunimasa; Shintaku-Kubota, Miyuki; Kojima-Koba, Yukiko; Ito, Naoko; Sugihara, Masako; Yamaaki, Naoto; Chujo, Daisuke; Nohara, Atsushi; Takeda, Yoshiyu; Kobayashi, Junji; Yamagishi, Masakazu; Higashida, Haruhiro
January 2009
Experimental Diabetes Research;2009, Special section p1
Academic Journal
Aims/hypothesis. ADP-ribosyl-cyclase activity (ADPRCA) of CD38 and other ectoenzymes mainly generate cyclic adenosine 5'diphosphate-(ADP-) ribose (cADPR) as a second messenger in various mammalian cells, including pancreatic beta cells and peripheral blood mononuclear cells (PBMCs). Since PBMCs contribute to the pathogenesis of diabetic nephropathy, ADPRCA of PBMCs could serve as a clinical prognostic marker for diabetic nephropathy. This study aimed to investigate the connection between ADPRCA in PBMCs and diabetic complications. Methods. PBMCs from 60 diabetic patients (10 for type 1 and 50 for type 2) and 15 nondiabetic controls were fluorometrically measured for ADPRCA based on the conversion of nicotinamide guanine dinucleotide (NGD+) into cyclic GDP-ribose. Results. ADPRCA negatively correlated with the level of HbA1c (P = .040, R² = .073), although ADPRCA showed no significant correlation with gender, age, BMI, blood pressure, level of fasting plasma glucose and lipid levels, as well as type, duration, or medication of diabetes. Interestingly, patients with nephropathy, but not other complications, presented significantly lower ADPRCA than those without nephropathy (P = .0198) and diabetes (P = .0332). ANCOVA analysis adjusted for HbA1c showed no significant correlation between ADPRCA and nephropathy. However, logistic regression analyses revealed that determinants for nephropathy were systolic blood pressure and ADPRCA, not HbA1c. Conclusion/interpretation. Decreased ADPRCA significantly correlated with diabetic nephropathy. ADPRCA in PBMCs would be an important marker associated with diabetic nephropathy.


Related Articles

  • Nephrin Is Expressed on the Surface of Insulin Vesicles and Facilitates Glucose-Stimulated Insulin Release. Fornoni, Alessia; Jeon, Jongmin; Santos, Javier Varona; Cobianchi, Lorenzo; Jauregui, Alexandra; Inverardi, Luca; Mandic, Slavena A.; Bark, Christina; Johnson, Kevin; McNamara, George; Pileggi, Antonello; Molano, R. Damaris; Reiser, Jochen; Tryggvason, Karl; Kerjaschki, Dontscho; Berggren, Per-Olof; Mundel, Peter; Ricordi, Camillo // Diabetes;Jan2010, Vol. 59 Issue 1, p190 

    OBJECTIVE--Nephrin, an immunoglobulin-like protein essential for the function of the glomerular podocyte and regulated in diabetic nephropathy, is also expressed in pancreatic β-cells, where its function remains unknown. The aim of this study was to investigate whether diabetes modulates...

  • Diabetic Peripheral Neuropathy: Role of Reactive Oxygen and Nitrogen Species. Premkumar, Louis; Pabbidi, Reddy // Cell Biochemistry & Biophysics;Nov2013, Vol. 67 Issue 2, p373 

    The prevalence of diabetes has reached epidemic proportions. There are two forms of diabetes: type 1 diabetes mellitus is due to auto-immune-mediated destruction of pancreatic β-cells resulting in absolute insulin deficiency and type 2 diabetes mellitus is due to reduced insulin secretion and...

  • Anti-CD38 autoantibodies: Characterisation in new-onset Type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies R. Mallone et al.: CD38 and islet autoimmunity in new-onset Type I and LADA patients. Mallone, R.; Ortolan, E.; Pinach, S.; Volante, M.; Zanone, M.; Bruno, G.; Baj, G.; Lohmann, T.; Cavallo-Perin, P.; Malavasi, F. // Diabetologia;Dec2002, Vol. 45 Issue 12, p1667 

    Aims/hypothesis. Serum anti-CD38 autoantibodies (aAbs) have been reported in 17 to 19% of patients with long-standing Type I (insulin-dependent) diabetes mellitus and Type II (non-insulin-dependent) diabetes mellitus. Whether these aAbs are also found in new-onset Type I diabetes and in Latent...

  • An accessible diabetes service for renal transplant recipients. Reed, Jo // Journal of Diabetes Nursing;2011, Vol. 15 Issue 7, p248 

    Renal and diabetes care are both highly specialised areas with high standards; a lack of synchronisation between the two can result in unstructured care for the person with renal failure and diabetes. In this article, the author reports the experience of implementing a DSN service within a renal...

  • Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus. Landgraf, R. // Drugs & Aging;2000, Vol. 17 Issue 5, p411 

    Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic β-cells to glucose is already markedly disturbed in the early stages of type 2...

  • Ethnic Differences in β-Cell Functional Reserve and Clinical Features in Patients With Ketosis-Prone Diabetes. Maldonado, Mario R.; Otiniano, Max E.; Lee, Rebekah; Rodriguez, Lucille; Balasubramanyam, Ashok // Diabetes Care;Aug2003, Vol. 26 Issue 8, p2469 

    Studies the ethnic differences in beta-cell functional reserve and clinical features in patients with ketosis-prone diabetes. Clinical and demographic characteristics of ketosis-prone indigent subjects; Results indicating that Hispanic patients are more likely to have better beta-cell reserve...

  • Murder mysteries in type 1 diabetes. Kaufman, Daniel L. // Nature Medicine;Feb2003, Vol. 9 Issue 2, p161 

    Discusses findings of a study that nervous system cells surrounding insulin-producing cells in the pancreas are destroyed early in the development of type 1 diabetes. Disease process; Prediagnostic markers and therapies; Onset of insulitis.

  • Altered Homeostatic Adaptation of First- and Second-Phase Î’-Cell Secretion in the Offspring of Patients With Type 2 Diabetes. Bonadonna, Riccardo C.; Stumvoll, Michael; Fritsche, Andreas; Muggeo, Michele; Häring, Hans; Bonora, Enzo; van Haeften, Timon W. // Diabetes;Feb2003, Vol. 52 Issue 2, p470 

    We adapted a minimal model to assess β-cell function during a hyperglycemic glucose clamp and to uncover peculiar aspects of the relationship among β-cell function, plasma glucose, and insulin sensitivity (IS) in offspring of Caucasian patients with type 2 diabetes (OfT2D). We pooled two...

  • The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes. Nielsen, Eva-Maria D.; Hansen, Lars; Carstensen, Bendix; Echwald, Søren M.; Drivsholm, Thomas; Glümer, Charlotte; Thorsteinsson, Birger; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf // Diabetes;Feb2003, Vol. 52 Issue 2, p573 

    The E23K polymorphism of the pancreatic β-cell ATPsensitive K[sup +] (K[sup ATP]) channel subunit Kir6.2 (KCNJ11) is associated with type 2 diabetes in whites, and a recent in vitro study of the E23K variant suggests that the association to diabetes might be explained by a slight inhibition...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics